Insights

Niche Market Focus Helsinn Therapeutics specializes in pharmaceutical manufacturing with a focus likely on niche or specialized therapeutic areas, offering opportunities to partner with suppliers, distributors, or service providers aiming to support targeted drug development.

Growing Revenue Potential With an estimated revenue between one to ten million dollars and a lean workforce, Helsinn presents a scalable growth opportunity, potentially receptive to customized products or services that enhance operational efficiency.

Indirect Competitor Landscape Operating in a competitive sector alongside industry giants like Roche, Johnson & Johnson, and Pfizer, Helsinn may seek innovative collaborations or technology solutions to differentiate and strengthen its market position.

US Market Entry Based in New Jersey, Helsinn's strategic location in the US offers opportunities to align with local regulators, supply chains, and healthcare providers, facilitating market expansion or new product launches.

Potential for Innovation Given the limited available details on recent developments, engaging Helsinn with advanced biotech, manufacturing automation, or compliance solutions could catalyze their R&D efforts and support growth in specialized treatment areas.

Helsinn Therapeutics (U.S.), Inc. Tech Stack

Media & News

Helsinn Therapeutics (U.S.), Inc.'s Email Address Formats

Helsinn Therapeutics (U.S.), Inc. uses at least 1 format(s):
Helsinn Therapeutics (U.S.), Inc. Email FormatsExamplePercentage
First.Last@helsinn.comJohn.Doe@helsinn.com
98%
LF@helsinn.comDJ@helsinn.com
1%
FL@helsinn.comJD@helsinn.com
1%

Frequently Asked Questions

Where is Helsinn Therapeutics (U.S.), Inc.'s headquarters located?

Minus sign iconPlus sign icon
Helsinn Therapeutics (U.S.), Inc.'s main headquarters is located at 170 Wood Avenue South Iselin, New Jersey 08830 United States. The company has employees across 1 continents, including North America.

What is Helsinn Therapeutics (U.S.), Inc.'s NAICS code?

Minus sign iconPlus sign icon
Helsinn Therapeutics (U.S.), Inc.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Helsinn Therapeutics (U.S.), Inc. have currently?

Minus sign iconPlus sign icon
As of December 2025, Helsinn Therapeutics (U.S.), Inc. has approximately 39 employees across 1 continents, including North America. Key team members include Head Of Corporate Business Development: D. R.Director Of Trade Distribution: C. C.Medical Science Director: J. U.. Explore Helsinn Therapeutics (U.S.), Inc.'s employee directory with LeadIQ.

What industry does Helsinn Therapeutics (U.S.), Inc. belong to?

Minus sign iconPlus sign icon
Helsinn Therapeutics (U.S.), Inc. operates in the Pharmaceutical Manufacturing industry.

What is Helsinn Therapeutics (U.S.), Inc.'s email format?

Minus sign iconPlus sign icon
Helsinn Therapeutics (U.S.), Inc.'s email format typically follows the pattern of First.Last@helsinn.com. Find more Helsinn Therapeutics (U.S.), Inc. email formats with LeadIQ.

When was Helsinn Therapeutics (U.S.), Inc. founded?

Minus sign iconPlus sign icon
Helsinn Therapeutics (U.S.), Inc. was founded in 2000.

Helsinn Therapeutics (U.S.), Inc.

Pharmaceutical ManufacturingNew Jersey, United States11-50 Employees

Helsinn Therapeutics (U.S.), Inc. is a pharmaceuticals company based out of 170 WOOD AVE S, Iselin, New Jersey, United States.

Section iconCompany Overview

Headquarters
170 Wood Avenue South Iselin, New Jersey 08830 United States
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2000
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $1M

    Helsinn Therapeutics (U.S.), Inc.'s revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    Helsinn Therapeutics (U.S.), Inc.'s revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

ยฉ LeadIQ, Inc. All rights reserved.